Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 22-Mar-24 4:51 PM View:  | Cymabay Therapeutics, Inc. (CBAY) | 22-Mar-24 | Disposition | 90,000 | -- | -- | (100%) 90.0K to 0 | |
| 29-Sep-23 5:54 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 29-Sep-23 | Option Exercise | 15,921 | $5.00 | $79,605.00 | 15% 108.41K to 124.33K | |
| 29-Sep-23 5:54 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 29-Sep-23 | Planned Option Sale | 15,921 | $15.68 | $249,675.00 | (13%) 124.33K to 108.41K | |
| 14-Apr-23 4:19 PM View: | Jasper Therapeutics, Inc. (JSPR) | 13-Apr-23 | Sale | 9,075 | $1.49 | $13,524.50 | (30%) 30.25K to 21.18K | |
| 13-Oct-22 8:05 PM View: | Jasper Therapeutics, Inc. (JSPR) | 12-Oct-22 | Grant | 30,250 | -- | -- | 100% 0 to 30.25K | |
| 18-May-21 8:10 PM View: | Vera Therapeutics, Inc. (VERA) | 18-May-21 | Conversion Duplicate | 2,187,500 | -- | -- | 12270% 17.83K to 2.21M | |
| 18-May-21 8:10 PM View: | Vera Therapeutics, Inc. (VERA) | 18-May-21 | Private Purchase | 772,727 | $11.00 | $8,500,000.00 | 35% 2.21M to 2.98M | |
| 18-May-21 8:10 PM View: | Vera Therapeutics, Inc. (VERA) | 17-May-21 | Market Purchase | 17,828 | $12.04 | $214,656.00 | 100% 0 to 17.83K | < 1% |
| 18-Jun-20 4:09 PM View: | Vaxcyte, Inc. (PCVX) | 16-Jun-20 | Conversion | 4,156,220 | -- | -- | 100% 0 to 4.16M | |
| 18-Jun-20 4:09 PM View: | Vaxcyte, Inc. (PCVX) | 16-Jun-20 | Purchase | 12,500 | $16.00 | $200,000.00 | < 1% 4.16M to 4.17M | |
| 19-Dec-18 4:18 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 18-Dec-18 | Sale | 53,492 | $7.43 | $397,365.00 | (18%) 292.84K to 239.35K | |
| 19-Dec-18 4:22 PM View: | Crispr Therapeutics Ag (CRSP) | 18-Dec-18 | Market Sale | 69,925 | $29.70 | $2,077,100.00 | (6%) 1.23M to 1.16M | (483%) |
| 19-Dec-18 4:18 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 17-Dec-18 | Sale | 88,889 | $8.17 | $726,223.00 | (23%) 381.73K to 292.84K | |
| 19-Dec-18 4:22 PM View: | Crispr Therapeutics Ag (CRSP) | 17-Dec-18 | Market Sale | 3,009 | $33.17 | $99,797.10 | (< 1%) 1.24M to 1.23M | (422%) |
| 07-Jun-18 7:30 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 05-Jun-18 | Sale | 920 | $12.51 | $11,509.20 | (< 1%) 384.65K to 383.73K | |
| 07-Jun-18 7:30 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 05-Jun-18 | Exercise (in-the money or at-the-money) | 2,000 | $5.75 | $11,500.00 | (< 1%) 383.73K to 381.73K | |
| 07-Jun-18 4:36 PM View: | Crispr Therapeutics Ag (CRSP) | 05-Jun-18 | Sale | 920 | $12.51 | $11,509.20 | (< 1%) 384.65K to 383.73K | |
| 07-Jun-18 4:36 PM View: | Crispr Therapeutics Ag (CRSP) | 05-Jun-18 | Exercise (in-the money or at-the-money) | 2,000 | $5.75 | $11,500.00 | (< 1%) 383.73K to 381.73K | |
| 15-May-18 8:04 PM View: | Crispr Therapeutics Ag (CRSP) | 14-May-18 | Market Sale | 400,000 | $55.36 | $22,142,600.00 | (24%) 1.64M to 1.24M | (213%) |
| 15-May-18 8:04 PM View: | Crispr Therapeutics Ag (CRSP) | 11-May-18 | Market Sale | 250,000 | $52.84 | $13,209,900.00 | (13%) 1.89M to 1.64M | (228%) |
| 07-Mar-18 4:19 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 05-Mar-18 | Sale (Planned) | 13,353 | $15.51 | $207,105.00 | (3%) 394.01K to 380.65K | |
| 20-Feb-18 4:08 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 15-Feb-18 | Sale (Planned) | 68,712 | $14.49 | $995,637.00 | (15%) 462.72K to 394.01K | |
| 15-Feb-18 4:12 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 14-Feb-18 | Sale (Planned) | 162,979 | $16.69 | $2,720,120.00 | (26%) 625.7K to 462.72K | |
| 15-Feb-18 4:12 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 13-Feb-18 | Sale (Planned) | 55,078 | $13.51 | $744,104.00 | (8%) 680.77K to 625.7K | |
| 09-Feb-18 4:17 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 07-Feb-18 | Sale (Planned) | 40,763 | $12.35 | $503,423.00 | (7%) 567.69K to 526.93K | |
| 07-Feb-18 4:20 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 05-Feb-18 | Sale (Planned) | 18,831 | $12.14 | $228,608.00 | (3%) 586.52K to 567.69K | |
| 05-Feb-18 4:07 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 02-Feb-18 | Sale (Planned) | 2,000 | $12.11 | $24,220.00 | (< 1%) 588.52K to 586.52K | |
| 05-Feb-18 4:07 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 01-Feb-18 | Sale (Planned) | 88,098 | $12.15 | $1,070,390.00 | (13%) 676.62K to 588.52K | |
| 01-Feb-18 4:29 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 31-Jan-18 | Sale (Planned) | 12,300 | $12.23 | $150,429.00 | (2%) 688.92K to 676.62K | |
| 01-Feb-18 4:29 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 30-Jan-18 | Sale (Planned) | 85,339 | $12.22 | $1,042,840.00 | (11%) 774.26K to 688.92K | |
| 26-Jan-18 8:40 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 25-Jan-18 | Sale (Planned) | 39,438 | $12.18 | $480,355.00 | (5%) 813.7K to 774.26K | |
| 24-Jan-18 4:02 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 22-Jan-18 | Sale (Planned) | 138,253 | $10.40 | $1,437,830.00 | (15%) 951.95K to 813.7K | |
| 22-Jan-18 5:26 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 19-Jan-18 | Sale (Planned) | 130,584 | $10.25 | $1,338,490.00 | (12%) 1.08M to 951.95K | |
| 22-Jan-18 5:26 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 18-Jan-18 | Sale (Planned) | 13,632 | $10.21 | $139,183.00 | (1%) 1.1M to 1.08M | |
| 09-Jan-18 4:34 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 05-Jan-18 | Sale (Planned) | 4,300 | $10.21 | $43,903.00 | (< 1%) 1.1M to 1.1M | |
| 11-Jan-18 9:00 PM View: | Crispr Therapeutics Ag (CRSP) | 05-Jan-18 | Market Purchase | 65,934 | $22.75 | $1,500,000.00 | 4% 1.82M to 1.89M | 661% |
| 09-Jan-18 4:39 PM View: | Crispr Therapeutics Ag (CRSP) | 05-Jan-18 | Market Sale (Planned) | 92,337 | $26.96 | $2,489,410.00 | (5%) 1.91M to 1.82M | (542%) |
| 04-Jan-18 5:29 PM View: | Crispr Therapeutics Ag (CRSP) | 02-Jan-18 | Market Sale (Planned) | 37,754 | $26.76 | $1,010,120.00 | (2%) 1.95M to 1.91M | (547%) |
| 27-Dec-17 4:08 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 22-Dec-17 | Sale (Planned) | 173,192 | $9.41 | $1,629,300.00 | (14%) 1.27M to 1.1M | |
| 14-Nov-17 5:48 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 10-Nov-17 | Sale (Planned) | 50,048 | $9.26 | $463,379.00 | (4%) 1.32M to 1.27M | |
| 03-Nov-17 4:52 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 01-Nov-17 | Sale (Planned) | 4,320 | $9.25 | $39,979.40 | (< 1%) 1.33M to 1.32M | |
| 01-Nov-17 4:39 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 31-Oct-17 | Sale (Planned) | 52,573 | $9.27 | $487,352.00 | (4%) 1.38M to 1.33M | |
| 01-Nov-17 4:39 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 30-Oct-17 | Sale (Planned) | 6,636 | $9.26 | $61,449.40 | (< 1%) 1.39M to 1.38M | |
| 04-Oct-17 4:02 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 03-Oct-17 | Sale | 70,940 | $7.81 | $554,041.00 | (5%) 1.46M to 1.39M | |
| 04-Oct-17 4:02 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 02-Oct-17 | Sale | 37,936 | $7.93 | $300,832.00 | (3%) 1.5M to 1.46M | |
| 02-Oct-17 5:20 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 29-Sep-17 | Sale | 120,735 | $8.04 | $970,709.00 | (7%) 1.62M to 1.5M | |
| 02-Oct-17 5:20 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 28-Sep-17 | Sale | 90,389 | $8.15 | $736,670.00 | (5%) 1.71M to 1.62M | |
| 30-Aug-17 4:18 PM View: | Crispr Therapeutics Ag (CRSP) | 28-Aug-17 | Market Sale (Planned) | 88,011 | $19.79 | $1,741,740.00 | (4%) 2.04M to 1.95M | (775%) |
| 28-Aug-17 4:33 PM View: | Crispr Therapeutics Ag (CRSP) | 25-Aug-17 | Market Sale (Planned) | 14,913 | $19.52 | $291,102.00 | (< 1%) 2.05M to 2.04M | (787%) |
| 28-Aug-17 4:33 PM View: | Crispr Therapeutics Ag (CRSP) | 24-Aug-17 | Market Sale (Planned) | 7,868 | $19.23 | $151,302.00 | (< 1%) 2.06M to 2.05M | (801%) |